These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 9404706)
41. Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial. Horibe K; Yumura-Yagi K; Kudoh T; Nishimura S; Oda M; Yoshida M; Komada Y; Hara J; Tawa A; Usami I; Tanizawa A; Kato K; Kobayashi R; Matsuo K; Hori H; J Pediatr Hematol Oncol; 2017 Mar; 39(2):81-89. PubMed ID: 28169879 [TBL] [Abstract][Full Text] [Related]
42. Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings. Watanabe N; Kobayashi H; Ichiji O; Yoshida MA; Kikuta A; Komada Y; Sekine I; Ishida Y; Horiukoshi Y; Tsunematsu Y; Yano M; Nakadate H; Kaneko Y Leukemia; 2003 May; 17(5):876-82. PubMed ID: 12750700 [TBL] [Abstract][Full Text] [Related]
43. Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia. Taki T; Ida K; Bessho F; Hanada R; Kikuchi A; Yamamoto K; Sako M; Tsuchida M; Seto M; Ueda R; Hayashi Y Leukemia; 1996 Aug; 10(8):1303-7. PubMed ID: 8709635 [TBL] [Abstract][Full Text] [Related]
44. Management of children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. An update of the Ontario experience. Barr RD; DeVeber LL; Pai KM; Andrew M; Halton J; Cairney AE; Whitton AC Am J Pediatr Hematol Oncol; 1992 May; 14(2):136-9. PubMed ID: 1530118 [TBL] [Abstract][Full Text] [Related]
45. Molecular cytogenetic analysis of gene rearrangements in childhood acute lymphoblastic leukemia. Woo HY; Kim DW; Park H; Seong KW; Koo HH; Kim SH J Korean Med Sci; 2005 Feb; 20(1):36-41. PubMed ID: 15716599 [TBL] [Abstract][Full Text] [Related]
46. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416 [TBL] [Abstract][Full Text] [Related]
50. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors. Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717 [TBL] [Abstract][Full Text] [Related]
51. Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen. Wiernik PH; Dutcher JP; Paietta E; Gucalp R; Markus S; Weinberg V; Azar C; Garl S; Benson L Leukemia; 1993 Aug; 7(8):1236-41. PubMed ID: 8350624 [TBL] [Abstract][Full Text] [Related]
52. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Fine BM; Stanulla M; Schrappe M; Ho M; Viehmann S; Harbott J; Boxer LM Blood; 2004 Feb; 103(3):1043-9. PubMed ID: 14525776 [TBL] [Abstract][Full Text] [Related]
53. Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study Group. Kobayashi T; Tobinai K; Shimoyama M; Mikuni C; Konda S; Kozuru M; Araki K; Sai T; Fukuhara S; Matsumoto M; Aoki I; Deura K; Oyama A; Hotta T; Abe T; Toki H; Nagai M; Fukuda H; Niimi M; Yamaguchi N; Tajima K; Shirakawa S Jpn J Clin Oncol; 1999 Jul; 29(7):340-8. PubMed ID: 10470659 [TBL] [Abstract][Full Text] [Related]
54. Lymphoblastic leukemia with mature B-cell phenotype in infancy. Frater JL; Batanian JR; O'Connor DM; Grosso LE J Pediatr Hematol Oncol; 2004 Oct; 26(10):672-7. PubMed ID: 15454841 [TBL] [Abstract][Full Text] [Related]
55. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750 [TBL] [Abstract][Full Text] [Related]
56. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. Waber DP; Carpentieri SC; Klar N; Silverman LB; Schwenn M; Hurwitz CA; Mullenix PJ; Tarbell NJ; Sallan SE J Pediatr Hematol Oncol; 2000; 22(3):206-13. PubMed ID: 10864051 [TBL] [Abstract][Full Text] [Related]
57. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652 [TBL] [Abstract][Full Text] [Related]
58. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699 [TBL] [Abstract][Full Text] [Related]
59. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Pieters R; Schrappe M; De Lorenzo P; Hann I; De Rossi G; Felice M; Hovi L; LeBlanc T; Szczepanski T; Ferster A; Janka G; Rubnitz J; Silverman L; Stary J; Campbell M; Li CK; Mann G; Suppiah R; Biondi A; Vora A; Valsecchi MG Lancet; 2007 Jul; 370(9583):240-250. PubMed ID: 17658395 [TBL] [Abstract][Full Text] [Related]
60. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Silverman LB; Stevenson KE; O'Brien JE; Asselin BL; Barr RD; Clavell L; Cole PD; Kelly KM; Laverdiere C; Michon B; Schorin MA; Schwartz CL; O'Holleran EW; Neuberg DS; Cohen HJ; Sallan SE Leukemia; 2010 Feb; 24(2):320-34. PubMed ID: 20016537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]